Novartis will acquire Mariana Oncology for up to $1.75 billion
Novartis will acquire Mariana Oncology, a fully integrated biotechnology company and pioneer in a new era of radiopharmaceutical innovation for treating people with cancer, for $1 billion upfront and up to $750 million in potential milestone payments, a statement noted….